Market Tracker

11/20 12:30pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

388.92
BATS BZX Real-Time Price
As of 12:30pm ET
 -2.67 / -0.68%
Today’s Change
340.09
Today|||52-Week Range
543.55
+5.95%
Year-to-Date
Regeneron Pharmaceuticals: Cramer's Top Takeaways
Nov 14 / TheStreet.com - Paid Partner Content
Regeneron (REGN) Beats on Q3 Earnings & Sales, Shares Up
Nov 08 / Zacks.com - Paid Partner Content
Breaking Down This Downturn: Cramer's 'Mad Money' Recap (Tuesday, 11/14/17)
Nov 14 / TheStreet.com - Paid Partner Content
Regeneron (REGN) Q3 Earnings Beat Estimates
Nov 08 / Zacks.com - Paid Partner Content
Inovio (INO) Q3 Loss Wider Than Expected, Revenues Miss
Nov 09 / Zacks.com - Paid Partner Content
Inovio (INO) Q3 Earnings: Is a Beat in Store for the Stock?
Nov 06 / Zacks.com - Paid Partner Content
Ophthotech (OPHT) Q3 Earnings & Sales Beat, Zimura in Focus
Nov 09 / Zacks.com - Paid Partner Content
Not Rewarding Surprises Like It Used To: Global Week Ahead
Nov 06 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold ...
Nov 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close391.59
Today’s open392.64
Day’s range385.35 - 393.30
Volume8,488
Average volume (3 months)784,698
Market cap$42.1B
Dividend yield--
Data as of 12:30pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+37.60%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+18.44%
P/E ratio35.3
Price/Sales8.79
Price/Book9.33

Competitors

 Today’s
change
Today’s
% change
SHPGShire-5.52-3.75%
VRTXVertex Pharmaceutica...-1.95-1.32%
BAXBaxter International...+0.05+0.08%
ALXNAlexion Pharmaceutic...-1.29-1.16%
Data as of 12:30pm ET, 11/20/2017

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)$4.43
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts